Alembic to commission Sikkim plant this fiscal

Companies like Intas Pharma, Torrent Pharma, Zydus Cadila etc already have facilities in Sikkim

Sohini Das Ahmedabad
Last Updated : Nov 02 2014 | 9:35 PM IST
Vadodara-based pharma company Alembic Pharmaceuticals is all set to commission its formulations plant in Sikkim within this fiscal.

The company hopes to bring down outsourcing of manufacturing for the domestic market from a current 50 per cent to 15 per cent within two years of commissioning the facility.

Alembic would join a host of companies from Gujarat which have set up manufacturing facilities in this north eastern state to take advantage of tax benefits.

Also Read

Companies like Intas Pharma, Torrent Pharma, Zydus Cadila etc already have facilities in Sikkim, where there is a ten year relief (from the date of commencement of commercial production) on central excise as well as income tax exemption, incentives on substantial expansion of capacity as well as capital investment subsidy.

Units that would start production within 10 years of the notification which came in 2007, would be eligible for these benefits for the next 10 years.

Alembic had firmed up plans for setting up a unit in the tax haven around 2008, and aims to commission the Rs 100 crore facility with a capacity of 2.5 billion tablets and capsules within the end of this fiscal.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 02 2014 | 8:58 PM IST

Next Story